Ellen Stelloo

Ellen Stelloo obtained her PhD at Leiden University. Her PhD focused on molecular classification of endometrial cancer to guide adjuvant treatment decisions. She performed her post-doctoral studies at University Medical Center Utrecht, where she generated patient-derived ovarian cancer organoids to study drug responses and used single-cell sequencing to capture the genomic consequence of chromatin errors during mitosis.

At Cergentis, Ellen is primarily responsible for managing clinical collaborations and execution of validation studies for oncology applications.